These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22113576)

  • 21. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.
    Lan Q; Zheng T; Rothman N; Zhang Y; Wang SS; Shen M; Berndt SI; Zahm SH; Holford TR; Leaderer B; Yeager M; Welch R; Boyle P; Zhang B; Zou K; Zhu Y; Chanock S
    Blood; 2006 May; 107(10):4101-8. PubMed ID: 16449530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H; Kadri AN; Hernandez AV
    Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vegetable and fruit intake and non-Hodgkin lymphoma survival in Connecticut women.
    Han X; Zheng T; Foss F; Holford TR; Ma S; Zhao P; Dai M; Kim C; Zhang Y; Bai Y; Zhang Y
    Leuk Lymphoma; 2010 Jun; 51(6):1047-54. PubMed ID: 20350273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course.
    Pamuk GE; Tozkir H; Uyanik MS; Gurkan H; Duymaz J; Pamuk ON
    Leuk Lymphoma; 2015; 56(10):2902-7. PubMed ID: 25699652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma.
    Skibola DR; Smith MT; Bracci PM; Hubbard AE; Agana L; Chi S; Holly EA
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1251-6. PubMed ID: 15894681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia.
    Lee KM; Lan Q; Kricker A; Purdue MP; Grulich AE; Vajdic CM; Turner J; Whitby D; Kang D; Chanock S; Rothman N; Armstrong BK
    Hum Genet; 2007 Dec; 122(5):525-33. PubMed ID: 17891500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A polymorphism at the microRNA binding site in the 3' untranslated region of C14orf101 is associated with non-Hodgkin lymphoma overall survival.
    Yang B; Liu C; Diao L; Wang C; Guo Z
    Cancer Genet; 2014 Apr; 207(4):141-6. PubMed ID: 24831772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma.
    Deng Q; Zheng T; Lan Q; Lan Y; Holford T; Chen Y; Dai M; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
    Eur J Cancer Prev; 2013 Jan; 22(1):77-82. PubMed ID: 22609637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Body mass index, weight change, and survival in non-Hodgkin lymphoma patients in Connecticut women.
    Han X; Stevens J; Bradshaw PT
    Nutr Cancer; 2013; 65(1):43-50. PubMed ID: 23368912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
    Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Comorbidity Models Within a Population-Based Cohort of Older Adults With Non-Hodgkin Lymphoma.
    Gordon MJ; Duan Z; Zhao H; Nastoupil L; Iyer S; Ferrajoli A; Danilov AV; Giordano SH
    JCO Clin Cancer Inform; 2024 Apr; 8():e2300223. PubMed ID: 38684043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
    Song H; Tong D; Cha Z; Bai J
    Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma.
    Gustafson HL; Yao S; Goldman BH; Lee K; Spier CM; LeBlanc ML; Rimsza LM; Cerhan JR; Habermann TM; Link BK; Maurer MJ; Slager SL; Persky DO; Miller TP; Fisher RI; Ambrosone CB; Briehl MM
    Am J Hematol; 2014 Jun; 89(6):639-45. PubMed ID: 24633940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence polymorphisms in the D-loop region of mitochondrial DNA and outcome of non-Hodgkin lymphoma.
    Diao L; Wei G; Su H; Li H; Song J; Gao Y; Guo Z
    Mitochondrial DNA; 2015 Feb; 26(1):88-91. PubMed ID: 24021008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
    Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
    Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival patterns among lymphoma patients with a family history of lymphoma.
    Anderson LA; Pfeiffer RM; Rapkin JS; Gridley G; Mellemkjaer L; Hemminki K; Björkholm M; Caporaso NE; Landgren O
    J Clin Oncol; 2008 Oct; 26(30):4958-65. PubMed ID: 18606984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional factors and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort.
    Leo QJ; Ollberding NJ; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L; Maskarinec G
    Eur J Clin Nutr; 2016 Jan; 70(1):41-6. PubMed ID: 26330148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.
    Lee JJ; Kim DH; Lee NY; Sohn SK; Kim JG; Kim HJ; Do YR; Park YH
    Br J Haematol; 2007 May; 137(4):329-36. PubMed ID: 17408400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.
    Drake MT; Maurer MJ; Link BK; Habermann TM; Ansell SM; Micallef IN; Kelly JL; Macon WR; Nowakowski GS; Inwards DJ; Johnston PB; Singh RJ; Allmer C; Slager SL; Weiner GJ; Witzig TE; Cerhan JR
    J Clin Oncol; 2010 Sep; 28(27):4191-8. PubMed ID: 20713849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
    Skibola CF; Bracci PM; Halperin E; Nieters A; Hubbard A; Paynter RA; Skibola DR; Agana L; Becker N; Tressler P; Forrest MS; Sankararaman S; Conde L; Holly EA; Smith MT
    PLoS One; 2008 Jun; 3(7):e2816. PubMed ID: 18636124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.